Skip to content

Comparison of short-term efficacy between MIS-TLIF and EndoLIF in the treatment of single-segment degenerative lumbar disease

Comparison of short-term efficacy between MIS-TLIF and EndoLIF in the treatment of single-segment degenerative lumbar disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043265
Enrollment
Unknown
Registered
2021-02-09
Start date
2020-01-01
Completion date
Unknown
Last updated
2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative lumbar disease

Interventions

Group 2:EndoLIF group

Sponsors

Jiangsu Taizhou People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: A retrospective analysis of 32 patients who underwent MIS-TLIF treatment in the Spine Surgery Department of Taizhou Peoples Hospital from June 2019 to October 2020. The inclusion criteria were: 1. Completed MIS-TLIF surgery; 2. Patients aged 18 to 70 years old; 3. The clinical symptoms are severe low back pain or low back and leg pain, with or without intermittent claudication; 4. After 3 to 6 months of strict conservative treatment, it is invalid; 5. Imaging manifestations of single-segment lumbar spondylolisthesis (degree I/II), lumbar spinal stenosis, and lumbar disc herniation, which are consistent with clinical symptoms; 6. Those who have no mental illness and cooperate with follow-up. Inclusion criteria for the EndoLIF group: 1. Subjects aged 18 to 70 years; 2. Clinical symptoms are severe low back pain or low back pain, with or without intermittent claudication; 3. Strict conservative treatment is ineffective after 3~6 months; 4. The imaging manifestations are single-segment spondylolisthesis (degree I/II), lumbar spinal stenosis, and lumbar disc herniation, which are consistent with clinical symptoms; 5. Those who have no mental illness, to be able to tolerate surgery and cooperate with follow-up.

Exclusion criteria

Exclusion criteria: Retrospective analysis of the MIS-TLIF group performed in the Spine Surgery of Taizhou Peoples Hospital from June 2019 to October 2020. 1. Those who were judged to be multi-level lumbar spine lesions by symptoms, signs, and imaging examinations; 2. Mental illness Patients with history; 3. patients with a history of lumbar spine surgery; 4. patients with severe osteoporosis (T value measured by dual-energy x-ray absorption method <=2.5); 5. patients who were lost to follow-up due to various reasons. Endo-LIF group: 1. Patients with multi-level lumbar spine lesions judged by symptoms, signs, and imaging examinations; 2. Patients with a history of mental illness; 3. Patients with other lumbar spine surgery history; 4. Severe osteoporosis Patients with severe disease (T value measured by dual-energy x-ray absorption method <=2.5); 5. Patients with clear surgical contraindications, such as severe heart disease, diabetes, renal failure, respiratory failure, coagulopathy and other serious medical diseases; 6. Patients who refuse to sign informed consent.

Design outcomes

Primary

MeasureTime frame
VAS;ODI;Complications;

Countries

China

Contacts

Public ContactLi Haijun

Jiangsu Taizhou People's Hospital

13901436563@qq.com+86 13901436563

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026